Li Zhu
Li Zhu, Shenzhen CN
Patent application number | Description | Published |
---|---|---|
20130227644 | SIPTO decision method and device for H(e)NB system - The disclosure claims a Selected Internet Protocol Traffic Offload (SIPTO) decision method and device for a Home (evolved) Node-B (H(e)NB) system, both the method and device can judge whether a H(e)NB has the SIPTO authority, and can allow the H(e)NB to implement the SIPTO if the H(e)NB has the SIPTO authority. The method and device of the disclosure can support the SIPTO of the H(e)NB. | 08-29-2013 |
20130326586 | Connection Processing Method and System - The disclosure provides a connection processing method and system. The method includes: establishing a secure connection between a Mobility Management Entity (MME) and/or Serving Gateway (S-GW) and a Home (Evolved) NodeB (H(e)NB); and protecting a connection between the MME and/or S-GW and the H(e)NB via the secure connection. The disclosure increases the reliability and security of a data transmission mechanism of an H(e)NB system, overcomes the security defects of the H(e)NB system, and improves the security performance of the H(e)NB system. | 12-05-2013 |
Li Zhu, Shanghai CN
Patent application number | Description | Published |
---|---|---|
20140018303 | 3-Amino-2-Hydroxy-4-Phenylbutanoyl-Valyl-Isoleucine, Preparation and Use Thereof - The present invention relates to a novel compound, 3-amino-2-hydroxy-4-phenylbutanoyl-valyl-isoleucine with structure showed below. | 01-16-2014 |
Li Zhu, Beijing CN
Patent application number | Description | Published |
---|---|---|
20140080804 | NOVEL 6-ARYLAMINO PYRIDONE CARBOXAMIDE AS MEK INHIBITORS - The invention provides novel substituted 6-arylamino pyridone carboxamides represented by Formula I, or a pharmaceutically acceptable salt, solvate, poly-morph, ester, tautomer or prodrug thereof, and a composition comprising these compounds. The compounds provided can be used as inhibitors of MEK and are useful in the treatment of inflammatory diseases, cancer and other hyperproliferative diseases. The invention further provides a method of treatment for inflammatory diseases, cancer and other hyperproliferative diseases in mammals, especially humans. | 03-20-2014 |
20150018341 | NOVEL ARYLALKENE DERIVATIVES AND USE THEREOF AS SELECTIVE ESTROGEN RECEPTOR MODULATORS - The invention provides novel ethylene derivatives represented by Formula I, which may be used as selective estrogen receptor modulators (SERMs) and useful in the prophylaxis and/or treatment of estrogen-dependent conditions or conditions. | 01-15-2015 |
20150223274 | NETWORK ASSISTED PROXIMITY SERVICE SESSION MANAGEMENT - There are provided measures for network assisted proximity service session management. Such measures exemplarily comprise discovering a proximity service target, said proximity service target providing proximity service, and setting up, via uplink and downlink signaling, proximity service communication with said proximity service target. | 08-06-2015 |
20150299171 | INHIBITORS OF BRUTON'S TYROSINE KINASE - The invention provides novel poly-substituted 5-membered heterocyclic compounds represented by Formula (IV), or a pharmaceutically acceptable salt, solvate, metabolites, polymorph, ester, tautomer or prodrug thereof, and a composition comprising these compounds. The compounds provided can be used as selective irreversible bruton's tyrosine kinase (Btk) inhibitors and is further useful to treat inflammatory, auto immune diseases associated with aberrant B-cell proliferation such as RA (rheumatoid arthritis) and cancers. This invention also provided the preparation of a medicament using of Formula (IV), and methods of preventing or treating diseases associated with excessive Btk activity in mammals, especially humans. Formula (IV) | 10-22-2015 |
Li Zhu, Richmond, CA US
Patent application number | Description | Published |
---|---|---|
20140353530 | POLARIZATION INDEPENDENT DUAL USAGE HCG VCSEL-DETECTOR WITH HIGH CONTRAST GRATING AND TWO DIMENSIONAL PERIOD STRUCTURE - A dual usage HCG VCSEL detector is provided with a high contrast grating (HCG) reflector first reflector that has a two dimensional periodic structure. The two dimensional structure is a periodic structure that is a symmetric structure with periodic repeating. The symmetrical structure provides that polarization modes of light are undistinguishable. A second reflector is in an opposing relationship to the first reflector. A tunable optical cavity is between the first and second reflectors. An active region is positioned in the cavity between the first and second reflectors. The photodetector is polarization independent. An MQW light absorber is included converts light to electrons. A dual usage HCG VCSEL-detector includes a high contrast grating (HCG) reflector first reflector, and a second reflector in an opposing relationship to the first reflector. A tunable optical cavity is between the first and second reflectors. An active region is positioned in the cavity between the first and second reflectors. The dual usage HCG VCSEL-detector that operates as a dual usage HCG VCSEL and as a tunable photodetector. | 12-04-2014 |
20140353583 | POLARIZATION INDEPENDENT PHOTODETECTOR WITH HIGH CONTRAST GRATING AND TWO DIMENSIONAL PERIOD STRUCTURE - A photodetector is provided with a high contrast grating (HCG) reflector first reflector that has a two dimensional periodic structure. The two dimensional structure is a periodic structure that is a symmetric structure with periodic repeating. The symmetrical structure provides that polarization modes of light are undistinguishable. A second reflector is in an opposing relationship to the first reflector. A tunable optical cavity is between the first and second reflectors. An active region is positioned in the cavity between the first and second reflectors. The photodetector is polarization independent. An MQW light absorber is included converts light to electrons. | 12-04-2014 |
Li Zhu, Willetton AU
Patent application number | Description | Published |
---|---|---|
20150229779 | PROXIMITY SERVICE CHARGING - A mechanism for a user equipment is described. The mechanism comprises allocating a secure memory area, wherein said secure memory area being inaccessible by a user of the user equipment; generating an charging identifier relating to proximity communication involving the user equipment; collecting proximity service charging data during the proximity communication; storing the charging identifier and the proximity service charging data in the secure memory area. | 08-13-2015 |
Li Zhu, Berkeley, CA US
Patent application number | Description | Published |
---|---|---|
20150286006 | HIGH EFFICIENCY VERTICAL OPTICAL COUPLER USING SUB-WAVELENGTH HIGH CONTRAST GRATING - A vertical optical coupler which redirects light transmission in response to the interaction between a sub-wavelength high contrast grating (HCG) having a plurality of spaced apart segments of grating material which is optically coupled to a waveguide. For a selected set of material, grating geometry, gaps and spacing, the light directed at a normal incidence into the optical coupler is angularly displaced in traveling in the optical waveguide, while light directed along the optical waveguide is angularly displaced in being output at normal incidence from the optical coupler. The coupler is integrated into a number of device embodiments, including: a coupler between angularly displaced waveguides, lasers, light emitting diodes (LEDs) and solar cells. | 10-08-2015 |
Li Zhu, Niskayuna, NY US
Patent application number | Description | Published |
---|---|---|
20160123926 | METHODS OF ISOLATING NUCLEIC ACIDS UNDER REDUCED DEGRADATION CONDITION - A method of isolating nucleic acids from a biological material, comprises applying the biological material on a substrate comprising one or more cell lysis reagents impregnated therein; applying a fluid to the biological material applied on the substrate; extracting the nucleic acids from the biological material applied on the substrate; and collecting the extracted nucleic acids in a substantially intact form, wherein the collected nucleic acid has a molecular weight greater than or equal to 20 kb. | 05-05-2016 |